Skip to main content
62°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Business News
Pharmaceuticals
Health care industry
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Companies
Business
US: News
From
CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
Tags
Targa Resources Corp
Taylor Morrison Home Corp
Williams Companies Inc
From
CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
UnitedHealth Group Inc
Breaking News: Business
Politics
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotechnology
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Healthy Returns
Roche Holding AG
Social issues
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
AstraZeneca PLC
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Pharmaceuticals
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Social issues
Abbott Laboratories
Healthy Returns
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Breaking News: Markets
Business News
Europe News
From
CNBC.com News
CNBC Daily Open: Everyone's waiting for Nvidia
August 28, 2024
Tags
Market Outlook
Eli Lilly and Co
Cryptocurrency
From
CNBC.com News
CNBC Daily Open: Stocks up ahead of Nvidia earnings
August 27, 2024
Tags
Technology
Dell Technologies Inc
Censorship
From
CNBC.com News
5 things to know before the stock market opens Tuesday
August 27, 2024
Tags
Entertainment
Eli Lilly and Co
Paramount Global
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Companies
Business
US: News
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
Tags
Equity Residential
Eli Lilly and Co
Arch Capital Group Ltd
From
CNBC.com News
CNBC Daily Open: A 'crazy' summer
August 21, 2024
Tags
Lowe's Companies Inc
Economy
Hedge Funds
From
CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
Tags
Intellectual property violations
Market Outlook
Eli Lilly and Co
From
CNBC.com News
Wednesday's big stock stories: What's likely to move the market in the next trading session
August 20, 2024
Tags
Eli Lilly and Co
Target Corp
Netflix Inc
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Merck & Co Inc
Abbvie Inc
Politics
From
CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
Tags
GUESS? Inc
Applied Materials Inc
Mitsubishi Heavy Industries Ltd
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Pharmaceuticals
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
August 08, 2024
Tags
Business
Investment Strategy
U/S/ Markets
From
CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Health care industry
Biotechnology
Pharmaceuticals
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
August 07, 2024
Tags
PRO: Playbooks
Investing
Dollar Tree Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
August 05, 2024
Tags
CrowdStrike Holdings Inc
Walt Disney Co
Eli Lilly and Co
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Companies
Breaking news
US: News
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Pharmaceuticals
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
